Copenhagen 2009

Advances in HBV Treatment: 2009

AASLD 2008

Focus on Investigational HBV/HCV Agents

Advances in HBV Treatment With Approved Agents

Milan 2008

Update on Hepatitis B Management

Highlight on Special Hepatic Issues and Populations

Boston 2007

Highlight on Special Hepatic Issues and Populations

Clinical Updates in HBV Treatment

Washington 2007

New Data on Viral Hepatitis and Related Complications

Barcelona 2007

Advances in HBV Treatment: 2007

Highlight on Special Hepatic Issues and Populations

Boston 2006

Clinical Updates in HBV Treatment

Los Angeles 2006

New Data on Viral Hepatitis and Related Complications

HBV Workshop 2006

2006 Update on Hepatitis B Management

Vienna 2006

Updates in HBV Management

Shanghai 2006

New Developments in the Management of Chronic Hepatitis B

Hawaii 2005

Conference Report

San Francisco 2005

HCV Management: Facing New Challenges

Managing HCC and Liver Transplantation

Latest Findings in HBV Management

Bali 2005

New Data on Chronic Hepatitis B

Early HBeAg loss during peginterferon alfa-2b therapy predicts HBsAg loss: Results of a long-term follow-up study in chronic hepatitis B patients.

Buster EH, Flink HJ, Simsek H, et al. Am J Gastroenterol. 2009;104:2449-2457.

Capsule Summary | Expert Commentary | Abstract | Slides

Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.

Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF. Hepatology. 2009;49:1859-1867.

Capsule Summary | Expert Commentary | Abstract | Slides

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

Marcellin P, Heathcote EJ, Buti M, et al. N Engl J Med. 2008;359:2442-2455.

Capsule Summary | Expert Commentary | Abstract | Slides